The remdesivir trial was placebo controlled: ht
Post# of 148158
https://www.nih.gov/news-events/news-releases...d-covid-19
There is plenty to be critical about with this trial, mainly midstream changing the endpoints to fit what was being observed in other trials; but, it was placebo controlled.
We can expect much better results with leronlimab.